Holen Sie sich die Stockscreener-App
96.35
1.55%
1.2812
Finanzdaten der Revolution Medicines Inc-Aktie (RVMD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
14.70%
361.63
|
315.27 | 264.71 | 240.76 | 216.31 |
| Operating Income/Loss |
14.70%
-361.63
|
-315.27 | -264.71 | -240.76 | -216.31 |
| Nonoperating Income/Loss |
132.46%
-3.266
|
10.06 | 16.93 | 27.34 | 20.99 |
| Income/Loss From Continuing Operations Before Tax |
19.56%
-364.89
|
-305.21 | -247.79 | -213.42 | -195.32 |
| Income/Loss From Continuing Operations After Tax |
19.56%
-364.89
|
-305.21 | -247.79 | -213.42 | -194.57 |
|
Net Income/Loss
|
19.56%
-364.89
|
-305.21 | -247.79 | -213.42 | -194.57 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.22%
1.4716
|
189.23 | 188.58 | 188.15 | 2.1613 |
| Diluted Average Shares |
99.22%
1.4716
|
189.23 | 188.58 | 188.15 | 2.1613 |
| Basic Earnings Per Share |
17.39%
-1.89
|
-1.61 | -1.31 | -1.13 | -1.13 |
| Diluted Earnings Per Share |
17.39%
-1.89
|
-1.61 | -1.31 | -1.13 | -1.13 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):